ISG20 and hepatocellular carcinoma: In support of our observations, a previous study has shown that ISG20 overexpression in HCC tumours was correlated with clinical parameters, such as vascular invasion, AFP levels and tumour sizes, as well as with poorer recurrence-free survival in HCC patients [13].